SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-23-002490
Filing Date
2023-02-03
Accepted
2023-02-03 16:59:13
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 sabs20230127b_s3.htm S-3 423360
2 EXHIBIT 5.1 ex_471048.htm EX-5.1 10877
3 EXHIBIT 23.1 ex_471069.htm EX-23.1 2470
4 EXHIBIT FILING FEES ex_471047.htm EX-FILING FEES 31261
5 dentons01.jpg GRAPHIC 3200
  Complete submission text file 0001437749-23-002490.txt   473576
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269565 | Film No.: 23586909
SIC: 2836 Biological Products, (No Diagnostic Substances)